These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 22442201

  • 1. Antielastin B-cell and T-cell immunity in patients with chronic obstructive pulmonary disease.
    Rinaldi M, Lehouck A, Heulens N, Lavend'homme R, Carlier V, Saint-Remy JM, Decramer M, Gayan-Ramirez G, Janssens W.
    Thorax; 2012 Aug; 67(8):694-700. PubMed ID: 22442201
    [Abstract] [Full Text] [Related]

  • 2. Antielastin autoimmunity in tobacco smoking-induced emphysema.
    Lee SH, Goswami S, Grudo A, Song LZ, Bandi V, Goodnight-White S, Green L, Hacken-Bitar J, Huh J, Bakaeen F, Coxson HO, Cogswell S, Storness-Bliss C, Corry DB, Kheradmand F.
    Nat Med; 2007 May; 13(5):567-9. PubMed ID: 17450149
    [Abstract] [Full Text] [Related]

  • 3. Anti-proline-glycine-proline or antielastin autoantibodies are not evident in chronic inflammatory lung disease.
    Greene CM, Low TB, O'Neill SJ, McElvaney NG.
    Am J Respir Crit Care Med; 2010 Jan 01; 181(1):31-5. PubMed ID: 19762563
    [Abstract] [Full Text] [Related]

  • 4. Systemic CD4+ T-cell activation is correlated with FEV1 in smokers.
    Glader P, von Wachenfeldt K, Löfdahl CG.
    Respir Med; 2006 Jun 01; 100(6):1088-93. PubMed ID: 16246539
    [Abstract] [Full Text] [Related]

  • 5. Influence of smoking cessation on airway T lymphocyte subsets in COPD.
    Roos-Engstrand E, Ekstrand-Hammarström B, Pourazar J, Behndig AF, Bucht A, Blomberg A.
    COPD; 2009 Apr 01; 6(2):112-20. PubMed ID: 19378224
    [Abstract] [Full Text] [Related]

  • 6. The search for autoantibodies against elastin, collagen and decorin in COPD.
    Brandsma CA, Kerstjens HA, Geerlings M, Kerkhof M, Hylkema MN, Postma DS, Timens W.
    Eur Respir J; 2011 May 01; 37(5):1289-92. PubMed ID: 21532021
    [No Abstract] [Full Text] [Related]

  • 7. Increased intraepithelial T-cells in stable COPD.
    Löfdahl MJ, Roos-Engstrand E, Pourazar J, Bucht A, Dahlen B, Elmberger G, Blomberg A, Sköld CM.
    Respir Med; 2008 Dec 01; 102(12):1812-8. PubMed ID: 18706796
    [Abstract] [Full Text] [Related]

  • 8. Antinuclear autoantibodies are more prevalent in COPD in association with low body mass index but not with smoking history.
    Bonarius HP, Brandsma CA, Kerstjens HA, Koerts JA, Kerkhof M, Nizankowska-Mogilnicka E, Roozendaal C, Postma DS, Timens W.
    Thorax; 2011 Feb 01; 66(2):101-7. PubMed ID: 21047865
    [Abstract] [Full Text] [Related]

  • 9. Differential switching to IgG and IgA in active smoking COPD patients and healthy controls.
    Brandsma CA, Kerstjens HA, van Geffen WH, Geerlings M, Postma DS, Hylkema MN, Timens W.
    Eur Respir J; 2012 Aug 01; 40(2):313-21. PubMed ID: 22241744
    [Abstract] [Full Text] [Related]

  • 10. Phenotypic characterisation of T-lymphocytes in COPD: abnormal CD4+CD25+ regulatory T-lymphocyte response to tobacco smoking.
    Barceló B, Pons J, Ferrer JM, Sauleda J, Fuster A, Agustí AG.
    Eur Respir J; 2008 Mar 01; 31(3):555-62. PubMed ID: 18057064
    [Abstract] [Full Text] [Related]

  • 11. A novel insight into adaptive immunity in chronic obstructive pulmonary disease: B cell activating factor belonging to the tumor necrosis factor family.
    Polverino F, Baraldo S, Bazzan E, Agostini S, Turato G, Lunardi F, Balestro E, Damin M, Papi A, Maestrelli P, Calabrese F, Saetta M.
    Am J Respir Crit Care Med; 2010 Oct 15; 182(8):1011-9. PubMed ID: 20581172
    [Abstract] [Full Text] [Related]

  • 12. Distribution of γδ and other T-lymphocyte subsets in patients with chronic obstructive pulmonary disease and asthma.
    Urboniene D, Babusyte A, Lötvall J, Sakalauskas R, Sitkauskiene B.
    Respir Med; 2013 Mar 15; 107(3):413-23. PubMed ID: 23273406
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Increased proportion of Fas positive CD8+ cells in peripheral blood of patients with COPD.
    Domagała-Kulawik J, Hoser G, Dabrowska M, Chazan R.
    Respir Med; 2007 Jun 15; 101(6):1338-43. PubMed ID: 17118637
    [Abstract] [Full Text] [Related]

  • 15. Impaired systemic cell-mediated immunity and increased susceptibility to acute respiratory tract infections in patients with COPD.
    Takabatake N, Sata M, Abe S, Inoue S, Saito H, Yuki H, Shibata Y, Kubota I.
    Respir Med; 2005 Apr 15; 99(4):485-92. PubMed ID: 15763456
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The expression of Foxp3 and ROR gamma t in lung tissues from normal smokers and chronic obstructive pulmonary disease patients.
    Chu S, Zhong X, Zhang J, Lao Q, He Z, Bai J.
    Int Immunopharmacol; 2011 Nov 15; 11(11):1780-8. PubMed ID: 21791252
    [Abstract] [Full Text] [Related]

  • 18. Imbalance between subpopulations of regulatory T cells in COPD.
    Hou J, Sun Y, Hao Y, Zhuo J, Liu X, Bai P, Han J, Zheng X, Zeng H.
    Thorax; 2013 Dec 15; 68(12):1131-9. PubMed ID: 23749814
    [Abstract] [Full Text] [Related]

  • 19. Identification of patients with chronic obstructive pulmonary disease (COPD) by measurement of plasma biomarkers.
    Shaker SB, von Wachenfeldt KA, Larsson S, Mile I, Persdotter S, Dahlbäck M, Broberg P, Stoel B, Bach KS, Hestad M, Fehniger TE, Dirksen A.
    Clin Respir J; 2008 Jan 15; 2(1):17-25. PubMed ID: 20298300
    [Abstract] [Full Text] [Related]

  • 20. Innate immunity proteins in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis.
    Tsoumakidou M, Bouloukaki I, Thimaki K, Tzanakis N, Siafakas NM.
    Exp Lung Res; 2010 Aug 15; 36(6):373-80. PubMed ID: 20653472
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.